$CHWY

CHWY Is Still Down 34% This Year: Did CHWY Stock Just Find a Bottom?

Chewy (CHWY) shares rose 6% to $21.75, despite a 34% YTD decline. The company reported 7.3% sales growth, raised full-year revenue guidance, and maintained gross margin at 30.4%. Cash decreased to $611M due to acquisitions and share buybacks. The broader pet-care sector has underperformed, with the PAWZ ETF down 10% YTD. Investors await Q3 2026 results to assess margin expansion and potential bottom.

Original reporting
Published Sep 14, 2026, 7:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 8:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CHWY Is Still Down 34% This Year: Did CHWY Stock Just Find a Bottom? — source image
Decision brief

The 30-second read

$CHWYBullishMed
01

Why it matters

The earnings beat and guidance raise provide a catalyst for a short‑term bounce, but margin flatness and cash outflow remain concerns.

02

Market read

Chewy's earnings lift offers a modest buying opportunity amid a weak pet‑care sector.

03

What to watch

Liquidity strain from the Modern Animal acquisition and share repurchases could limit near‑term financial flexibility.

Relevance 8/10Novelty 8/10Timing: today

Background

Chewy's stock has fallen 34% YTD, lagging the broader pet‑care ETF PAWZ, which is down 10% YTD.

Company-level read

Ticker impact

$CHWYBullishMedium confidence
Context

Chewy reported Q3 2026 results: sales up 7.3% YoY, met estimates, and raised full-year revenue and adjusted EBITDA margin guidance.

Expected impact

Potential upside of 5‑10% over the next week if guidance holds.

Evidence & confidence

Guidance lift offsets flat margin; market already reacted with a 6% intraday gain, indicating buying interest.

Market effects

Pet‑care sector remains weak, but Chewy's raised outlook may set a benchmark for peers.

U.S. consumer discretionary sentiment modestly improved.

Limited; primarily affects U.S. retail investors focused on pet‑care stocks.

Counterpoint

Flat gross margin and declining cash suggest the rally may be premature; downside risk if margin pressure persists.

Key entities

  • Chewy

    U.S. online pet retailer (NYSE:CHWY).

  • Modern Animal

    Pet‑care acquisition completed in the quarter.

Related articles

$CHWYMed

Chewy rises as Goldman Sachs maintains Buy rating on stock

Chewy Inc. shares rose 6.78% to $19.06 after Goldman Sachs maintained a Buy rating but lowered its price target to $34 from $46. The company reported Q1 earnings beat but reduced its fiscal 2026 sales outlook, prompting multiple analysts to cut price targets. Chewy's stock is down 56.34% over the past year and trades near its 52-week low.

$CHWYMedAI 8/10

Is Chewy’s (CHWY) Margin Story Losing Steam, or Is a 48% Drop the Opportunity?

Chewy (CHWY) reported Q2 2026 net sales of $3.33B, up 7.3%, and adjusted EPS of $0.36. The company raised its full-year outlook, but analysts downgraded the stock and cut price targets. CHWY stock fell 10% intraday after the results. Active customers rose 3.8% to 21.7M. Organic revenue growth slowed to 5.7%, and adjusted EBITDA margin benefited from non-recurring items. Analysts debate whether the slowdown is cyclical or structural.

$CHWYMedAI 8/10

CHWY Stock Hits Over 1-Month Low After Flat Q2 Gross Margin Overshadows Raised Outlook

Chewy Inc. (CHWY) reported Q2 net sales of $3.33B, up 7.3% YoY, meeting estimates. Adjusted EPS rose to $0.36, missing estimates by 1%. Gross margin remained unchanged at 30.4%, while adjusted EBITDA increased 23.7% to $226.7M. Chewy raised its FY26 revenue outlook but narrowed EBITDA margin guidance. CHWY stock fell 7% in morning trade, hitting a one-month low.

$CHWYHighAI 9/10

Chewy (CHWY) Is Building a Recurring Revenue Moat Through Autoship and a Vet Care Health Platform

Chewy (CHWY) reported Q2 FY2026 revenue of $3.33B, up 7.3% YoY, with Autoship sales at 84.6% of total. Active customers grew 3.8% YoY to 21.7M. Gross margin was 30.4%, and net income was $80.5M. Management raised full-year guidance, targeting $13.46B-$13.57B in net sales. Chewy Health and Vet Care showed strong growth, with 47 clinics and plans for 10-12 more.

$CHWYMedAI 8/10

CHWY Slides As Chewy Warns On Consumer Weakness

Chewy Inc. (CHWY) shares fell 3.23% due to concerns over slowing pet spending and competition. The company reported Q2 revenue of $3.33B and net income of $80.5M, with thin margins. Analysts downgraded CHWY, citing slowing growth and lack of near-term catalysts. The stock is in a downtrend, with resistance at $21.25.

$CHWYMed

CHWY Stock Slides As Chewy Warns On Pet Spending Outlook

Chewy Inc. (CHWY) stock fell 3.7% after reporting Q2 revenue of $3.33B and net income of $80.5M, with cautious consumer demand trends. Analysts note high valuation and slowing growth, with CHWY trading at 34x P/E and ~20x cash flow. The stock broke down to $20.30, with key support at $20 and resistance at $21.50.